Clinical Trial: Expanding Genetic Access for Prostate Cancer Survivors

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618520) titled 'Expanding Genetic Access for Prostate Cancer Survivors' on May 25.

Brief Summary: The goal of this study is to increase genetic education and genetic testing for hereditary cancer risk among prostate cancer survivors. The study will:

Test the effectiveness of a digital guide (DG+) vs. print guide (Print+) vs. enhanced usual care (EUC) on engagement in genetic education and uptake of genetic testing.

Evaluate the impact of the DG+ vs. Print+ vs. EUC on the process that participants use to make decisions and evaluate effects on well-being (also called psychosocial outcomes).

Explore the ways (methods) that influence how participants...